Haemodialysis dose is independent of type of surgically-created vascular access.

BACKGROUND In the United States, the use of polytertraflouroethylene (PTFE) graft compared with native arteriovenous fistula (AVF) for haemodialysis vascular access has been increasing despite a greater than twofold higher incidence of thrombosis and infection associated with PTFE grafts. METHODS We studied 214 haemodialysis patients with not more than two revisions of their vascular access, to determine whether any relationship exists between the type of haemodialysis vascular access and dialysis dose assessed primarily by urea reduction ratio (per cent reduction in blood urea nitrogen concentration after a dialysis session). Serum albumin concentration was used as a secondary outcome measure of dialysis adequacy. Urea reduction ratio and predialysis serum albumin concentration were measured at onset of study and at 4-week intervals and mean values were calculated for each subject. RESULTS The 214 patients (118 males, 96 females) included 173 Blacks (81%), 26 Whites (15%), and 15 Hispanics (7%), of mean (+/-SD) age 55.6+/-15.5 years. Of these 214 subjects, 111 (52%) had a native AVF, while 103 (48%) had a PTFE graft. Both mean urea reduction ratio (native AVF=69 +/-6.7% vs PTFE graft=70+/-7.3%; P=0.31), and mean serum albumin concentration (native AVF=4.02+/-0.39 g/dl vs PTFE graft=4+/-0.33 g/dl; P= 0.59) were equivalent in both groups. Separate multiple logistic regression analyses with type of vascular access as one of the independent variables, found no significant relationship between type of vascular access and either a urea reduction ratio > 65% (P= 0.67), or a serum albumin concentration >4g/dl (P=0.89), after adjustment for age of vascular access, access revision, location of access, dialyser urea clearance, length of dialysis treatment, body weight, and age. CONCLUSION We conclude that PTFE grafts do not permit delivery of better dialysis than native AVF. The increasing use of PTFE grafts in the United States does not have any clinical justification.

[1]  O. Ifudu,et al.  Standardized Hemodialysis Prescriptions Promote Inadequate Treatment in Patients with Large Body Mass , 1998, Annals of Internal Medicine.

[2]  W. Owen,et al.  Anemia in hemodialysis patients: variables affecting this outcome predictor. , 1997, Journal of the American Society of Nephrology : JASN.

[3]  J. Sands,et al.  Increasing numbers of AV fistulas for hemodialysis access. , 1997, Clinical nephrology.

[4]  H. Feldman,et al.  Hemodialysis vascular access morbidity. , 1996, Journal of the American Society of Nephrology : JASN.

[5]  E. Friedman,et al.  The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. , 1996, The New England journal of medicine.

[6]  M. Rothstein,et al.  Vascular access thrombosis in new hemodialysis patients. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  R M Hakim,et al.  Effects of dose of dialysis on morbidity and mortality. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  D. Churchill,et al.  Probability of thrombosis of vascular access among hemodialysis patients treated with recombinant human erythropoietin. , 1994, Journal of the American Society of Nephrology : JASN.

[9]  E. Friedman,et al.  Pervasive failed rehabilitation in center-based maintenance hemodialysis patients. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  E G Lowrie,et al.  The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. , 1993, The New England journal of medicine.

[11]  J. Berlin,et al.  Hemodialysis vascular access morbidity in the United States. , 1993, Kidney international.

[12]  E. Friedman,et al.  Determinants of type of initial hemodialysis vascular access. , 1997, American journal of nephrology.

[13]  E. Friedman,et al.  Correlates of vascular access and nonvascular access-related hospitalizations in hemodialysis patients. , 1996, American journal of nephrology.

[14]  B. Hylander,et al.  THE MULTINATIONAL STUDY OF DIALYSIS THERAPY: HEMODIALYSIS ACCESS , 1995 .

[15]  Marija J. Norusis,et al.  SPSS for Windows, Advanced Statistics, release 6.0 , 1993 .